Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ishares Neuroscience and Healthcare ETF (IBRN)

Ishares Neuroscience and Healthcare ETF (IBRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 4,897,500
  • Shares Outstanding, K 150
  • 60-Month Beta 0.93
  • Price/Earnings ttm 19.33
  • Annual Dividend & Yield 0.10 (0.31%)
  • Most Recent Dividend 0.101 on 12/17/24
  • Management Fee 0.47%

Options Overview Details

View History
  • Implied Volatility 52.33% (+52.33%)
  • Historical Volatility 29.14%
  • IV Percentile 42%
  • IV Rank 47.20%
  • IV High 67.29% on 10/21/25
  • IV Low 38.95% on 07/08/25
  • Expected Move (DTE 12) 0.00 (0.00%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 562
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 15
  • Open Int (30-Day) 29
  • Expected Range 32.65 to 32.65

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.70 +17.87%
on 11/07/25
32.85 -0.61%
on 12/05/25
+4.37 (+15.46%)
since 11/05/25
3-Month
25.42 +28.44%
on 09/15/25
32.85 -0.61%
on 12/05/25
+6.75 (+26.05%)
since 09/05/25
52-Week
17.86 +82.81%
on 04/09/25
32.85 -0.61%
on 12/05/25
+6.19 (+23.42%)
since 12/05/24

Most Recent Stories

More News
Do Wall Street Analysts Like Biogen Stock?

Biogen has significantly underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

C : 108.88 (+1.01%)
$SPX : 6,870.40 (+0.19%)
IBRN : 32.65 (+2.13%)
BIIB : 181.30 (-0.37%)
Biogen Stock Outlook: Is Wall Street Bullish or Bearish?

Biogen has lagged well behind the broader market over the past year, yet analysts maintain a fairly optimistic outlook on its future performance.

$SPX : 6,870.40 (+0.19%)
IBRN : 32.65 (+2.13%)
PIPR : 351.24 (+3.71%)
BIIB : 181.30 (-0.37%)
NVR Stock: Analyst Estimates & Ratings

Over the past year, NVR has delivered performance that surpasses the broader market. However, Wall Street analysts are cautious about its growth outlook.

$SPX : 6,870.40 (+0.19%)
ITB : 102.71 (-0.61%)
IBRN : 32.65 (+2.13%)
UBS : 40.64 (+4.72%)
NVR : 7,538.08 (+0.24%)
Are Wall Street Analysts Predicting Biogen Stock Will Climb or Sink?

Biogen has significantly underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,870.40 (+0.19%)
IBRN : 32.65 (+2.13%)
BIIB : 181.30 (-0.37%)
What Are Wall Street Analysts' Target Price for Lennar Stock?

Lennar has significantly outperformed the broader market over the past year, yet analysts are moderately bullish on the stock's outlook.

LEN : 123.91 (-2.24%)
WFC : 89.83 (-0.42%)
$SPX : 6,870.40 (+0.19%)
ITB : 102.71 (-0.61%)
IBRN : 32.65 (+2.13%)
Is Wall Street Bullish or Bearish on Biogen Stock?

Despite Biogen’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.

$SPX : 6,870.40 (+0.19%)
IBRN : 32.65 (+2.13%)
BIIB : 181.30 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Neuroscience and Healthcare ETF seeks to track the investment results of an index composed of U.S. and non-U.S. companies that could benefit from the growth and innovation in neuroscience.

See More

Key Turning Points

3rd Resistance Point 32.98
2nd Resistance Point 32.92
1st Resistance Point 32.78
Last Price 32.65
1st Support Level 32.58
2nd Support Level 32.52
3rd Support Level 32.38

See More

52-Week High 32.85
Last Price 32.65
Fibonacci 61.8% 27.12
Fibonacci 50% 25.35
Fibonacci 38.2% 23.59
52-Week Low 17.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar